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Volume 53, Number 17S Abstracts 89SScratch-plate assay was performed on a HUVEC mono-
layer. Treatments were as above and migration across the
“wound” was assessed at 0, 12, 24hrs. All experiments were
done in triplicate.
Results: LPS is a ligand for TLR4 receptors. HUVECs
cultured on Matrigel had increased tubule length when
treated with LPS (136% 3.2 of control), an effect that was
lost the in presence of apyrase (102.9%  4.4,
P0.001)(Figure). LPS with heat-inactivated apyrase
maintained tubule length (133.6% 10.7, P0.008). Mi-
gration was affected similarly, with the stimulatory effect of
LPS lost in the presence of apyrase.
Conclusions: TLR4 activation by LPS was pro-angio-
genic in HUVECs. This effect was in part mediated by
extracellular purinergic signalling. Future studies will ex-
amine the role of purinergic signalling on angiogenesis in
vivo.
Author Disclosures: T. R. Billiar: Nothing to disclose; X.
Cui: Nothing to disclose; R. McEnaney: Nothing to dis-
close; U. Sachdev: Nothing to disclose; E. Tzeng: Noth-
ing to disclose.
PS230.
EVAR: The Effect of Hooks and Oversizing on the
Strength of Proximal Fixation of the Stent Graft
Samuel S. Zhou1, Thien How2, Richard McWilliams3,
John Brennan4. 1Vascular Surgery, Raigmore Hospital,
Inverness, United Kingdom; 2Department of Clinical En-
gineering,University of Liverpool, Liverpool, United King-
dom; 3Department of Interventional Radiology, Royal Liv-
erpool University Hospital, Liverpool, United Kingdom;
4Department of Vascular Surgery, Royal Liverpool Univer-
sity Hospital, Liverpool, United Kingdom
Objectives: Stent-graft migration is an important cause
of late proximal endoleak and rupture after EVAR. The aim
of this study was to examine the relationship between
oversizing (diameter of stent-graft relative to diameter of eortic neck) and the force required to displace a stent-graft
ith and without hooks.
Methods: Truncated Zenith stent-grafts with and
ithout (Group1 and 2) hooks were deployed in pres-
urised bovine aorta in vitro. Stent-grafts were oversized by
, 10, 20, 30, 40 and 50 percent. The displacement force
DF) required to cause 5mm migration of the stent-graft
as measured by means of a force-gauge attached to the
tent-graft. The relationship between percentage oversize
nd DF in both groups was analysed.
Results: In group-1, Oversizing from 5% to 30% re-
ulted in significant increase in the mean DF from 1.036N
o 4.64N (P0.05). Increase in oversizing 30% was not
ssociated with further significant increase in mean DF. In
roup-2, an increase in the percentage of oversize from 5%
o 20% resulted in a significant increase in mean DF from
.066N to 6.047N ((P0.05). Oversizing beyond 20%
ad no additional effect. At each interval of oversizing
eanDF in group 2 was significantly greater that in group1
P0.05).
Conclusions: The present of hooks improving the
ecurity of proximal fixation is confirmed. Fixation is not
mproved significantly by oversizing more than 20% (with
ooks) or 30% (without hooks). This has implications when
lanning EVAR.
uthor Disclosures: J. Brennan: Nothing to disclose; T.
ow: Nothing to disclose; R. McWilliams: Nothing to
isclose; S. S. Zhou: Nothing to disclose.
S232.
ong-Term Effects of Everolimus-Eluting Self-Ex-
anding Stent Implantation in an Experimental Model
f Peripheral Vascular Intervention
ugh Zhao1, Alexander Nikanorov1, Renu Virmani2,
ewis B. Schwartz1. 1Abbott Vascular, Santa Clara, CA;
CVPath Institute Inc, Gaithersburg, MD
Objectives: The purpose of this study was to assess the
ascular response of everolimus eluting self-expanding
tents in the peripheral arteries of healthy swine.
Methods: The normal bilateral iliac arties of 24 Yu-
atan mini-swine were percutaneously treated with
mmx28 mm intravascular self-expanding nitinol stents;
are metal stents (BMS) were implanted on one side and
rug eluting stents (DES) on the contralateral side. The
rug eluting stents were coated with everolimus 225 ug/
m2 in a polymer matrix and intended to deliver the drug in
sustained fashion over about 6 months. After 3, 6 or 12
onths, the animals were sacrificed, the stented iliac arter-
es perfusion-fixed, and sections stained for histomorpho-
etric analysis (n8).
Results: The chronic presence of everolimus in arterial
issue reduced stent-induced inflammation and neointimal
yperplasia after 3 and 6 months, although some late
nflammation and remodeling were observed after drug
xhaustion at later times (Fig. 1). Interestingly, the stent-
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June Supplement 201190S Abstractsinduced atherosclerotic change characterized by the histo-
logic presence of foamy macrophages and cholesterol clefts
had been fully attenuated by the chronic presence of
everolimus.
Conclusions: In this experimental animal model, long-
term local arterial stent-mediated delivery of everolimus
inhibited the formation of early neointimal hyperplasia and
atherosclerosis.
Author Disclosures: A. Nikanorov: Abbott Vascular,Em-
ployment (full or part-time); L. B. Schwartz: Abbott
Laboratories, Employment (full or part-time);R. Virmani:
Abbott Vascular, Consulting fees or other remuneration
(payment); H. Zhao: Abbott Vascular,Employment (full
or part-time).
PS234.
Edaravone Suppresses Reperfusion Injury following
Leg Ischemia in Rats: Transmission Electro Micro-
scopic Study
Mitsuhiro Yamamaura, Yuji Miyamoto, MasatakaMitsuno,
Hiroe Tanaka, Masaaki Ryomoto, Shinya Fukui, Yoshiteru
Yoshioka. Dept. of Cardiovascular Surgery, Hyogo College
of Medicine, Nishinomiya, Japan
Objectives: It is well known that free radicals cause
reperfusion injury after leg ischemia. At Vascular Annual
Meeting 2010, our pathohistological study of Periodic
Acid Schiff staining showed that the free-radical scavenger,
edaravone (Radicut®, Mitsubishi Tanabe Pharma Co., Ja-
pan) suppressed reperfusion injury and maintained high
glycogen stores in lower extremity muscles. In the present
study, we used transmission electro microscope (TEM) to
elucidate how edaravone suppresses reperfusion injury.
Methods: Male Lewis rats (632  89 gm) were intra-
Fig. 1. Measurement of neointimal thickness (mm) by histomor-
phometry and representative images for BMS and DES at 3, 6 and
12 months post-implantation.peritoneally injected with edaravone (3.0 mg/kg, edara- oone group, n  3) or the same dose of saline (control
roup, n 3). Reperfusion injury models were induced by
lamping bilateral common femoral arteries for 5 hours and
hen de-clamping. At least 5 hours after reperfusion, the
ransverse sections of lower extremity muscles were imme-
iately made using a diamond knife. Under a TEM (JEM-
220, NipponDenshi Co., Japan), we counted the number
f glycogen-granules at 50,000x magnification on each 5
ifferent fields.
Results: The TEM sections from the control group
howed marked loss of glycogen-granules with swollen
itochondria. In contrast, the TEM sections from the
daravone group showed numerous glycogen-granules and
ormal mitochondria (Figure). The mean density of glyco-
en-granules in the edaravone group was significantly
igher than that in the control group (88.6  5.4 vs.
1.6  3.0 particles/m2, p  0.001).
Conclusions: Our TEM results confirmed that edara-
one suppresses reperfusion injury following leg ischemia
y maintaining the glycogen-granules in muscles.
uthor Disclosures: S. Fukui: Nothing to disclose; M.
itsuno: Nothing to disclose; Y. Miyamoto: Nothing to
isclose; M. Ryomoto: Nothing to disclose; H. Tanaka:
othing to disclose; M. Yamamaura: Grant-in Aid for
esearchers, Hyogo College of Medicine 2010,Research
rants; Y. Yoshioka: Nothing to disclose.
S236.
yperglycemia-Induced Adult Dermal Fibroblast Dys-
unction
dam J. Doyle, John P. Cullen, Elisa Roztocil, David
illespie. Vascular Surgery, University of Rochester Medi-
al Center, Rochester, NY
Objectives: Dermal fibroblasts are key cells in wound
ealing and remodeling by secreting MMP-2, MMP-9 and
GF-
. Patients with metabolic syndrome and diabetes
ith subsequent hyperglycemia are at increased risk of
mpaired wound healing. Although the effects of hypergly-
emia are well characterized in many different tissues, little
s known about the effects on dermal fibroblast function.
e hypothesize that hyperglycemia causes decreased rates
f proliferation and MMP-2, MMP-9 and TGF-
 secre-
